Selected Bibliography - Trends in 21st Century Epidemiology: From Scientific Discoveries to Population Health Impact

Session 1: Setting the Stage: The Evolution of Epidemiology and its Applications to Cancer

• Greenwald P and Dunn BK. Landmarks in the History of Cancer Epidemiology. Cancer Res. 2009; 69(6): 2151-8.
• Khoury MJ, Freedman AN, Gillanders, EM et al. Frontiers in Cancer Epidemiology: A Challenge to the Research Community from the Epidemiology and Genomics Research Program at the National Cancer Institute. Cancer Epidemiol Biomakers Prev. 2012 Jul;21(7):999-1001.
• Khoury MJ, Coates RJ, Fennell ML, Glasgow RE, Scheuner MT, Schully SD. Multilevel research and the challenges of implementing genomic medicine. J Natl Cancer Inst Monogr. 2012 May;2012(44):112-20.
• Lam TK, Spitz M, Schully SD et al. "Drivers" of translational cancer epidemiology in the 21st century: needs and opportunities. Cancer Epidemiol Biomarkers Prev. 2013 Jan [Epub ahead of print]

Session 2: The Impact of New Methods and Technologies on Epidemiologic Research

• Eysenbach G. Infodemiology and infoveillance tracking online health information and cyberbehavior for public health. Am J Prev Med. 2011 May;40(5 Suppl 2):S154-8.
• Liotta LA, Petricoin EF 3rd. -omics and cancer biomarkers: link to the biological truth or bear the consequences. Cancer Epidemiol Biomarkers Prev. 2012 Aug;21(8):1229-35.
• Salathé M, Bengtsson L, Bodnar TJ, Brewer DD, Brownstein JS, Buckee C, Campbell EM, Cattuto C, Khandelwal S, Mabry PL, Vespignani A. Digital epidemiology. PLoS Comput Biol. 2012 Jul;8(7):e1002616.
• Verma M, Khoury MJ, Ioannidis JP. Opportunities and Challenges for Selected Emerging Technologies in Cancer Epidemiology: Mitochondrial, Epigenomic, Metabolomic, and Telomerase Profiling. Cancer Epidemiol Biomarkers Prev. 2012 Dec 14. [Epub ahead of print]
• Witte JS. Of models and methods. Cancer Epidemiol Biomarkers Prev. 2011 Jun;20(6):1059-60.

Session 3: The Evolution of Epidemiologic Cohorts in the Study of Natural History of Cancer and Other Diseases

• Elena JW, Travis LB, Simonds NI, Ambrosone CB, Ballard-Barbash R, Bhatia S, Cerhan JR, Hartge P, Heist RS, Kushi LH, Lash TL, Morton LM, Onel K, Pierce JP, Robison LL, Rowland JH, Schrag D, Seminara D, Shu XO, Ulrich CM, Freedman AN. Leveraging Epidemiology and Clinical Studies of Cancer Outcomes: Recommendations and Opportunities for Translational Research. JNCI. [Epub ahead of print.]
• Rosenberg PS, Anderson WF. Age-period-cohort models in cancer surveillance research: ready for prime time? Cancer Epidemiol Biomarkers Prev. 2011 Jul;20(7):1263-8.
• Thun MJ, Hoover RN, Hunter DJ. Bigger, better, sooner - scaling up for success. CEBP. 2012 Apr;21(4):571-5.

Session 4: Use of Epidemiologic Research to Advance Clinical and Public Health Practice: Bridging the Evidence Gap with Observational Studies and Randomized Clinical Trials

• Ablin RJ. The United States Preventive Services Task Force recommendation against prostate-specific antigen screening--point. Cancer Epidemiol Biomarkers Prev. 2012 Mar;21(3):391-4.
• Gehlet S, Colditz, GA. Cancer disparities: unmet challenges in the elimination of disparities. Cancer Epidemiol Biomarkers Prev. 2011 Sep;20(9):1809-14.
• Khoury MJ, Gwinn M, Ioannidis JP. The emergence of translational epidemiology: from scientific discovery to population health impact. Am J Epidemiol. 2010 Sep 1;172(5):517-24.
• Robison LL, Demark-Wahnefried W. Cancer survivorship: focusing on future research opportunities. Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):1994-5.

Session 5: Use of Epidemiology in Knowledge Integration and Meta-Research

• Galea S, Riddle M, Kaplan GA. Causal thinking and complex system approaches in epidemiology. Int J Epidemiol. 2010 Feb;39(1):97-106.
• Ioannidis JP, Schully S, Lam TK, Khoury MJ. Knowledge Integration in Cancer: Current Landscape and Future Prospects. Cancer Epidemiol Biomarkers Prev. 2013 Jan; 22(1): 3-10
• Khoury MJ, Gwinn M, Dotson WD, Schully SD. Knowledge integration at the center of genomic medicine. Genetic Med. 2012 May 3; 14: 643-7.

Return to Top